Welcome to our dedicated page for Shift4 Payments SEC filings (Ticker: FOUR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Shift4 Payments processes billions of tokenized transactions for hotels, restaurants, stadium concession stands, and e-commerce checkouts—each revenue stream carries its own disclosure nuance. Investors often ask, “Where can I find Shift4 insider trading Form 4 transactions?� or “How did net processing revenue move in the latest Shift4 quarterly earnings report 10-Q filing?� The answers hide in dense documents.
Stock Titan’s platform brings those filings to you in real time and makes them readable. Our AI-powered summaries turn a 300-page Shift4 annual report 10-K simplified into a two-minute brief, highlight every new risk factor, and tag segment volume so understanding Shift4 SEC documents with AI feels effortless. When a sudden acquisition posts, you’ll see the Shift4 8-K material events explained before the market absorbs them. Need executive details? Receive Shift4 executive stock transactions Form 4 alerts within seconds—Shift4 Form 4 insider transactions real-time, not hours later.
What practical insights do these forms provide?
- 10-Q: Track payment-volume growth and gateway take-rate with a Shift4 earnings report filing analysis.
- 10-K: Review competitive landscape, deferred revenue, and technology capitalisation—all Shift4 SEC filings explained simply.
- Form 4: Monitor insider sentiment through each executive transaction.
- Proxy: Examine Shift4 proxy statement executive compensation and board incentives.
- 8-K: Follow contract wins or system outages as they happen.
With comprehensive coverage, AI-powered search, and exportable data, you can move from raw filings to confident decisions in minutes—no more sifting through EDGAR alone.
InfuSystem Holdings (INFU) Q2-25 10-Q highlights:
- Revenue: Q2 net sales rose 6.8% YoY to $36.0 m; 1H-25 up 7.6% to $70.7 m.
- Margin expansion: Gross margin improved to 55.2% (49.5% LY) on lower cost of revenues; operating margin doubled to 10.5%.
- Earnings: Q2 net income jumped 262% to $2.6 m (dil. EPS $0.12); 1H swung to $2.3 m profit from a $0.4 m loss.
- Segment mix: Patient Services delivered $21.5 m (+6.3%) with 64.1% gross margin; Device Solutions $14.5 m (+7.7%) with profit more than doubling to $6.1 m.
- Cash flow: Operating cash inflow surged to $8.8 m (vs $2.7 m). Free cash flow was $4.4 m after $4.3 m capex & a $1.4 m tuck-in acquisition (Apollo Medical Supply).
- Balance sheet: Cash climbed to $0.7 m; revolver borrowings increased to $26.6 m, lifting net debt to ~$25.9 m. Leverage ratio remains <3.5Ă— covenant. Equity declined $3.0 m to $54.5 m due mainly to $7.6 m share buybacks (1.15 m shares) under the $20 m program.
- Headcount costs: SG&A up 8.7% YoY to $16.1 m, largely in G&A (+14%).
- Hedging: Interest-rate swap carried $0.95 m asset (down from $1.48 m) reflecting higher rates; $0.4 m of related AOCI expected to flow to P&L within 12 mos.
- Post-quarter events: Revolver maturity extended to July 2030 (Second Amendment) with no covenant changes.
Investment takeaways: Accelerating top-line growth, widening margins and strong operating cash generation signal execution on both Patient Services and higher-margin Device Solutions. Balance-sheet flexibility preserved via revolver extension, though rising leverage and ongoing buybacks merit monitoring.
Form 3 snapshot: On 07/07/2025, Singapore-based investor Yip Tsz Yan purchased a majority interest in A SPAC II (Holdings) Corp. (“Sponsor�), giving her indirect voting and investment control over the Sponsor’s stake in A SPAC II Acquisition Corp. (ASUUF). The filing classifies Yip as a 10 % beneficial owner of the issuer.
- Ordinary shares held (indirect): 5,000,000
- Warrants held (indirect): to acquire 8,966,000 Class A ordinary shares
- Exercise price: $11.50 per share
- Warrant timing: Exercisable on the later of (i) completion of the SPAC’s initial business combination or (ii) 05/02/2023; expire five years after a business combination
The disclosure signals a change in the controlling ownership of the Sponsor, consolidating significant influence over the SPAC’s future merger decisions. If fully exercised, the warrants could add cash at $11.50 per share but would increase the share count by up to 8.97 million, creating potential dilution for existing holders.
Shift4 Payments, Inc. (NYSE: FOUR) filed an 8-K disclosing two material events that fundamentally reshape its capital structure and strategic profile.
1. Credit Facilities Amendment (Item 1.01). On 30 June 2025 the company’s main operating subsidiary executed Amendment No. 2 to its Second Amended & Restated First Lien Credit Agreement. Key changes are:
- Revolving Credit Facility upsized by $100 million to $550 million (up to $137.5 million L/C sub-limit; $50 million swing line).
- New $1.0 billion senior secured Term Loan Facility maturing 3 July 2032.
- Interest pricing: Term SOFR +2.75 % (term loan) / +2.00 % (revolver) with a 0 % floor, or ABR +1.75 % / +1.00 % alternatives. One 25 bp margin step-down tied to net leverage.
- Springing secured-net-leverage covenant of �3.10×, tested quarterly when revolver utilisation exceeds 40 %.
- Customary negative covenants, guarantees by domestic subsidiaries and first-priority liens on substantially all assets.
2. Completion of Global Blue Acquisition (Item 2.01). The cash tender offer by wholly owned subsidiary GT Holding 1 GmbH for Global Blue Group Holding AG expired 2 July 2025 with 97.37 % of shares (233.9 million) tendered. Shift4 accepted all shares for payment at: $7.50 (common), $10.00 (Series A pref), $11.81 (Series B pref). Outstanding options and RSUs were cash-settled; warrants remain outstanding but repriced. Total consideration � $2.7 billion.
Financing package:
- $1.0 billion draw under the new Term Loan Facility.
- Issuance of 10 million shares of 6.00 % Series A Mandatory Convertible Preferred Stock for net proceeds of $975 million.
- Senior notes: �680 million 5.50 % due 2033 and $550 million 6.75 % due 2032 (aggregate net proceeds � $1.282 billion).
- Balance funded with cash on hand.
Implications for investors. The acquisition gives Shift4 near-total ownership of a global tax-free shopping and payments platform, expanding its international footprint and cross-border capabilities. However, the deal is highly leveraged: new secured debt plus senior notes add roughly $2.83 billion gross debt and mandatory convertible preferred shares introduce potential dilution in 2028 (expected conversion window). Covenants limit future flexibility, though maturities are staggered (2029 revolver, 2032 term loan, 2032-33 senior notes). Successful integration and realisation of synergies will be critical to offset higher interest expense and leverage risk.
United Parks & Resorts Inc. (PRKS) filed a Form 4 on 07/02/2025 disclosing an equity grant to non-executive director Aayushi Dalal. The filing covers a 06/30/2025 transaction in which the director acquired 108 common shares—comprising 54 restricted stock units (RSUs) and 54 deferred stock units (DSUs)—under the company’s 2017 Omnibus Incentive Plan. The award vests 100% immediately; DSU shares will be issued three months after the director’s separation from service.
- Transaction code: “A� (award/grant)
- Price reported: $47.33 per share (grant-date fair value)
- Post-grant beneficial ownership: 5,466 PRKS shares held directly
- Reporting person role: Independent Director (not an officer or 10% owner)
The grant is routine board compensation and increases Dalal’s direct stake by roughly 2% relative to her prior holdings, a modest but positive alignment signal. No derivative securities were reported, and there is no indication that the transaction is part of a Rule 10b5-1 trading plan. The filing does not disclose broader financial results or strategic developments; its relevance is limited to corporate governance and insider-ownership monitoring.
United Parks & Resorts Inc. (PRKS) filed a Form 4 on 07/02/2025 disclosing an equity grant to non-executive director Aayushi Dalal. The filing covers a 06/30/2025 transaction in which the director acquired 108 common shares—comprising 54 restricted stock units (RSUs) and 54 deferred stock units (DSUs)—under the company’s 2017 Omnibus Incentive Plan. The award vests 100% immediately; DSU shares will be issued three months after the director’s separation from service.
- Transaction code: “A� (award/grant)
- Price reported: $47.33 per share (grant-date fair value)
- Post-grant beneficial ownership: 5,466 PRKS shares held directly
- Reporting person role: Independent Director (not an officer or 10% owner)
The grant is routine board compensation and increases Dalal’s direct stake by roughly 2% relative to her prior holdings, a modest but positive alignment signal. No derivative securities were reported, and there is no indication that the transaction is part of a Rule 10b5-1 trading plan. The filing does not disclose broader financial results or strategic developments; its relevance is limited to corporate governance and insider-ownership monitoring.
Streamline Health Solutions, Inc. (Nasdaq: STRM) has filed a preliminary Schedule 14A seeking stockholder approval for its $5.34-per-share all-cash merger with Mist Holding Co., the parent of MDaudit. At closing, Merger Sub will merge into Streamline, which will become a wholly-owned subsidiary of MDaudit and cease to be publicly traded.
Key economic terms
- Cash consideration of $5.34 per share, representing a 138 % premium to the 5/28/25 close and 117 % to the 30-day VWAP.
- No financing contingency; Parent states it has sufficient cash on hand to fund the deal and related costs.
- Options and warrants with exercise prices below $5.34 will be cashed-out; all currently outstanding options and warrants are “out-of-the-money� and will be cancelled for no consideration.
- Termination fee payable by Streamline to Parent is $950 K; no reverse termination fee disclosed.
Governance & process
- The Streamline Board unanimously approved the merger, deemed it fair, and recommends voting “FOR� all proposals.
- Cain Brothers rendered a fairness opinion to the Board on 5/28/25.
- Certain directors and officers entered into Voting & Support Agreements, committing their shares to support the transaction (exact percentage not yet specified).
- Completion requires the affirmative vote of at least 66 2/3 % of outstanding shares. Failure to vote counts as an “AGAINST.�
Timeline & conditions
- Special Meeting will be held virtually on a date to be set; record date also to be set.
- Expected closing is Q3 2025, subject to stockholder approval and customary conditions (no financing or regulatory conditions highlighted).
- Outside date for termination is 12/31/25.
Post-closing the STRM shares will be delisted from Nasdaq and deregistered under the Exchange Act. Stockholders who properly perfect appraisal rights under Delaware law may seek a court-determined “fair value� instead of the $5.34 cash payment.
Credit Acceptance Corp. (NASDAQ: CACC) has filed an 8-K announcing execution of the Fourteenth Amendment to its $� revolving secured line of credit with Comerica Bank and a syndicate of lenders. The sole material change is an extension of the revolving period by 12 months—from 22 Jun 2027 to 22 Jun 2028. All other economic covenants, collateral requirements and pricing terms remain unchanged. As of the amendment date (24 Jun 2025), the Company had no outstanding borrowings under the facility, leaving the entire committed capacity available as contingent liquidity. The amendment appears to be routine and does not create additional debt; rather, it preserves an existing liquidity back-stop for a longer horizon. A related press release (Ex. 99.1) and the amended agreement (Ex. 4.155) were filed concurrently.
The filing does not disclose the credit line’s current size, pricing grid, or covenant thresholds, and it contains no earnings guidance, financial results, or changes in strategy. Therefore, the immediate market impact is expected to be modest, though the extension modestly strengthens the Company’s liquidity profile and financial flexibility.